Related Experiment Video
Updated: Mar 24, 2026
10:21
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
10.6K
[Chemokines in chronic myeloid leukemia]
Naofumi Mukaida1, Tomohisa Baba
1Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University.
Summary
Targeting chemokines like CXCL12 and CCL3 may offer new strategies against chronic myeloid leukemia (CML). Understanding CML cell interactions within the bone marrow microenvironment is key to overcoming drug resistance and improving patient outcomes.
Area of Science:
- Oncology
- Hematology
- Molecular Biology
Context:
- Chronic myeloid leukemia (CML) is characterized by the BCR-ABL fusion gene.
- Tyrosine kinase inhibitors (TKIs) have improved CML patient outcomes.
- CML cells interact with the bone marrow microenvironment, leading to TKI resistance.
Purpose:
- To elucidate the cellular and molecular basis of CML cell interactions with normal hematopoietic cells.
- To investigate the roles of chemokines, specifically CXCL12 and CCL3, in bone marrow microenvironment reconstruction by CML cells.
Summary:
- BCR-ABL-expressing CML cells compete with normal hematopoietic cells for bone marrow space.
- CML cells exploit the bone marrow microenvironment to develop resistance to TKIs.
- Chemokines CXCL12 and CCL3 play significant roles in CML cell-mediated bone marrow microenvironment alterations.
Impact:
- Identifying novel therapeutic targets for CML treatment.
- Developing new treatment strategies to overcome TKI resistance in CML.
- Potential for chemokine-targeted therapies to improve CML management and patient survival.
Related Concept Videos
01:15Differentiation of Common Myeloid Progenitor Cells
4.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K
01:27Disorders of Leukocytes
2.4K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.4K
01:01Regulation of Hematopoietic Stem Cells
4.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.3K
02:30Metastasis
6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
01:15Receptor Downregulation in MVBs
3.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
3.0K